7
Nov
Medications
Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Understand what manufacturing changes trigger FDA re-evaluation for generic drugs, including PAS, CBE, and Annual Report submissions, review timelines, and how new programs are speeding up approvals for U.S.-made products.